Our top pick for
Nemaura Medical Inc is a medical devices business based in the US. Nemaura Medical shares (NMRD) are listed on the NASDAQ and all prices are listed in US Dollars. Nemaura Medical employs 25 staff and has a market cap (total outstanding shares value) of 0.00.
|Latest market close||$5.92|
|52-week range||$3.30 - $17.40|
|50-day moving average||$6.23|
|200-day moving average||$8.16|
|Wall St. target price||$18.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.37|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||2.07%|
|1 month (2021-09-20)||-3.11%|
|3 months (2021-07-20)||-26.09%|
|6 months (2021-04-20)||20.57%|
|1 year (2020-10-19)||54.97%|
|2 years (2019-10-18)||689.33%|
|3 years (2018-10-19)||177.93%|
|5 years (2016-10-19)||227.07%|
|Gross profit TTM||$0|
|Return on assets TTM||-14.84%|
|Return on equity TTM||-171.28%|
|Market capitalisation||$135.9 million|
TTM: trailing 12 months
There are currently 382,898 Nemaura Medical shares held short by investors – that's known as Nemaura Medical's "short interest". This figure is 18.3% down from 468,578 last month.
There are a few different ways that this level of interest in shorting Nemaura Medical shares can be evaluated.
Nemaura Medical's "short interest ratio" (SIR) is the quantity of Nemaura Medical shares currently shorted divided by the average quantity of Nemaura Medical shares traded daily (recently around 53929.295774648). Nemaura Medical's SIR currently stands at 7.1. In other words for every 100,000 Nemaura Medical shares traded daily on the market, roughly 7100 shares are currently held short.
However Nemaura Medical's short interest can also be evaluated against the total number of Nemaura Medical shares, or, against the total number of tradable Nemaura Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Nemaura Medical's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Nemaura Medical shares in existence, roughly 20 shares are currently held short) or 0.0417% of the tradable shares (for every 100,000 tradable Nemaura Medical shares, roughly 42 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Nemaura Medical.
Find out more about how you can short Nemaura Medical stock.
We're not expecting Nemaura Medical to pay a dividend over the next 12 months.
Nemaura Medical's shares were split on a 1:10 basis on 4 December 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Nemaura Medical shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Nemaura Medical shares which in turn could have impacted Nemaura Medical's share price.
Over the last 12 months, Nemaura Medical's shares have ranged in value from as little as $3.3013 up to $17.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nemaura Medical's is -0.3212. This would suggest that Nemaura Medical's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Nemaura Medical has bucked the trend.
Nemaura Medical Inc. , a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company was founded in 2009 and is based in New York, New York. .
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.